Beverage company Zevia (NYSE: ZVIA) will be reporting earnings this Wednesday after market close. Here’s what to look for.
Zevia beat analysts’ revenue expectations last quarter, reporting revenues of $46.09 million, up 21.2% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and an impressive beat of analysts’ EBITDA estimates.
Is Zevia a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Zevia’s revenue to be flat year on year, slowing from the 10.1% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Zevia has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Zevia’s peers in the beverages, alcohol, and tobacco segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Vita Coco delivered year-on-year revenue growth of 28.1%, beating analysts’ expectations by 3%, and Philip Morris reported revenues up 10.4%, topping estimates by 5.5%. Vita Coco traded down 11.4% following the results while Philip Morris was up 1.6%.
Read our full analysis of Vita Coco’s results here and Philip Morris’s results here.
Investors in the beverages, alcohol, and tobacco segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Zevia is down 1.2% during the same time and is heading into earnings with an average analyst price target of $3.71 (compared to the current share price of $1.69).
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
